ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some ...

The FDA has given marketing authorization to Zyn nicotine pouches. That doesn't necessarily mean they're safe to use, ...

UBS upgraded British American Tobacco (BTI) to Buy from Neutral with a price target of 3,900 GBp, up from 3,000 GBp. The firm views the stock’s ...

Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...

UBS upgraded British American Tobacco on Monday to ‘buy’ from ‘neutral’, hiked the price target to 3,900p from 3,000p and made the stock its ‘top pick’.

VELO x Lab54 presents the VELO [A]PRÈS PARTY, a series of winter parties launching in major UK cities — for your chance to ...

The Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, marking the first such move by the regulator for the fast-growing nicotine pouches segment. The ...

British American Tobacco was the top performer on the index as UBS upgraded it to ‘buy’ from ‘neutral’, hiked the price ...

WASHINGTON — Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit ...

Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...